Substrate-dependent inactivation of recombinant paraoxonase 1 during catalytic dihydrocoumarin turnover and the protective properties of surfactants

Chem Biol Interact. 2023 Sep 1:382:110563. doi: 10.1016/j.cbi.2023.110563. Epub 2023 Jun 5.

Abstract

Human paraoxonase-1 (PON1) is the most studied member of the paraoxonases (PONs) family and catalyzes the hydrolysis of various substrates (lactones, aryl esters, and paraoxon). Numerous studies link PON1 to oxidative stress-related diseases such as cardiovascular disease, diabetes, HIV infection, autism, Parkinson's, and Alzheimer's, where the kinetic behavior of an enzyme is characterized by initial rates or by modern methods that obtain enzyme kinetic parameters by fitting the computed curves over the entire time-courses of product formation (progress curves). In the analysis of progress curves, the behavior of PON1 during hydrolytically catalyzed turnover cycles is unknown. Hence, progress curves for enzyme-catalyzed hydrolysis of the lactone substrate dihydrocoumarin (DHC) by recombinant PON1 (rePON1) were analyzed to investigate the effect of catalytic DHC turnover on the stability of rePON1. Although rePON1 was significantly inactivated during the catalytic DHC turnover, its activity was not lost due to the product inhibition or spontaneous inactivation of rePON1 in the sample buffers. Examination of the progress curves of DHC hydrolysis by rePON1 led to the conclusion that rePON1 inactivates itself during catalytic DHC turnover hydrolysis. Moreover, human serum albumin or surfactants protected rePON1 from inactivation during this catalytic process, which is significant because the activity of PON1 in clinical samples is measured in the presence of albumin.

Keywords: Catalytic turnover; Enzyme stabilization by surfactants; Paraoxonase; Progress curve analysis; Substrate-dependent enzyme inactivation.

MeSH terms

  • Aryldialkylphosphatase* / chemistry
  • Aryldialkylphosphatase* / pharmacology
  • Catalysis
  • HIV Infections*
  • Humans
  • Hydrolysis
  • Surface-Active Agents

Substances

  • Aryldialkylphosphatase
  • Surface-Active Agents
  • PON1 protein, human